Back
NovoCure Vs. Equifax Industry Stock Comparison
Buy
61
NVCR
NovoCure
Last Price:
22.19
Seasonality Move:
12.1%
Buy
75
EFX
Equifax
Last Price:
249.93
Seasonality Move:
3.14%
Buy
61
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $22.17. The Score for NVCR is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Equifax (EFX)
is a Buy
Is Equifax a Buy, Sell or Hold?
- The current Equifax [EFX] share price is $249.94. The Score for EFX is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- EFX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EFX Stock Price Chart
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.79 | Buy |
Relative Strength Index (14 RSI): | 86.3 | Buy |
Chaikin Money Flow: | 1385306 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
EFX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.41 | Buy |
Relative Strength Index (14 RSI): | 61.85 | Buy |
Chaikin Money Flow: | -165123 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (221.76 - 243.3) | Buy |
Bollinger Bands (100): | (235.12 - 262.38) | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.21 | Buy |
20-day SMA: | 15.06 | Buy |
50-day SMA: | 14.55 | Buy |
200-day SMA: | 16.18 | Buy |
8-day EMA: | 18.77 | Buy |
20-day EMA: | 16.36 | Buy |
50-day EMA: | 15.09 | Buy |
200-day EMA: | 21.81 | Buy |
EFX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 243.15 | Buy |
20-day SMA: | 231.47 | Buy |
50-day SMA: | 246.36 | Buy |
200-day SMA: | 223.17 | Buy |
8-day EMA: | 243.49 | Buy |
20-day EMA: | 238.8 | Buy |
50-day EMA: | 242.08 | Buy |
200-day EMA: | 231.48 | Buy |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.16 per share.
Equifax Earnings Growth & EFX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.25 per share, an increase this year of $0.73 per share, and an increase next year of $2.17 per share.
NovoCure Technical Analysis
May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Equifax Technical Analysis
May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |